|
Post by JHam on Dec 18, 2014 16:10:05 GMT
Not that I know much about reading charts but finally this one is starting to turn around. I hope it continues but I still can't explain the cause of the drop to even these levels ($3.38 at the moment). We have a beautiful "golden goblet" forming and with those bolinger bands tightening every day, we are clearly set for a breakout!.... OK I have no idea what I am talking about I have never been a chart reader, however I think people are starting to come back in as we get closer to the end of the year. I was hoping to add more today in he $3.20s, but now that it is at $3.45 I may wait.
|
|
|
Post by JHam on Dec 18, 2014 20:58:32 GMT
Just added another small chunk at $3.47. Paid more than I wanted, but it was still less than my cost average (barely), and it seems like maybe there is legs to this recent runup. The volume is been growing more and more each day. Maybe some news tomorrow or early next week? Early Christmas present perhaps?
|
|
|
Post by JHam on Dec 18, 2014 21:05:56 GMT
Just added a small chunk at $3.08. Data should be any day now. I think the CEO said that he may wait to reveal the data in a conference sometime in Jan or early next year. But this does seem to be a good entry point considering that it's beaten down for no reason. I sold 2/3 of my position at $3.00 and put it into CUR. Pity it is going up now. Never mind that's life. Happy for the ones who held thru the bottom Wasn't the last presentation Rodman & Renshaw? I remember him sayin there that they'd have data out in Q4, but that the new IND would be announced first half of 2015. I could be wrong though. Anyway, here is the slide showing the milestones from Rodman & Renshaw which was in Nov: thebiotechinvestor.freeforums.net/attachment/download/135
|
|
|
Post by RLC on Dec 18, 2014 21:17:03 GMT
Just added another small chunk at $3.47. Paid more than I wanted, but it was still less than my cost average (barely), and it seems like maybe there is legs to this recent runup. The volume is been growing more and more each day. Maybe some news tomorrow or early next week? Early Christmas present perhaps? They just passed the 50-day MA today of $3.41 which is always nice to see. I thought I bought in at bargain prices on this one (averaged @ $3.57), but I was clearly wrong. Looking forward to results being released and really can't imagine much downside from here...
|
|
|
Post by JHam on Dec 18, 2014 21:23:56 GMT
Just added another small chunk at $3.47. Paid more than I wanted, but it was still less than my cost average (barely), and it seems like maybe there is legs to this recent runup. The volume is been growing more and more each day. Maybe some news tomorrow or early next week? Early Christmas present perhaps? They just passed the 50-day MA today of $3.41 which is always nice to see. I thought I bought in at bargain prices on this one (averaged @ $3.57), but I was clearly wrong. Looking forward to results being released and really can't imagine much downside from here... You and me both. However in our (my) defense, I think most expected that Phase 2a data would be released in conjunction with the up-list. Since they waited (or since they up-listed before the data was ready to be released), it was basically just a sitting duck on the Nasdaq with no strong news to back up the move. So I don't think the thesis was wrong here, just bad luck for us with the timing of data. I do plan on taking with this one since dilution is undoubtedly on its way.
|
|
|
Post by dayanand33 on Dec 19, 2014 13:46:18 GMT
I think the CEO said that he may wait to reveal the data in a conference sometime in Jan or early next year. But this does seem to be a good entry point considering that it's beaten down for no reason. I sold 2/3 of my position at $3.00 and put it into CUR. Pity it is going up now. Never mind that's life. Happy for the ones who held thru the bottom Wasn't the last presentation Rodman & Renshaw? I remember him sayin there that they'd have data out in Q4, but that the new IND would be announced first half of 2015. I could be wrong though. Anyway, here is the slide showing the milestones from Rodman & Renshaw which was in Nov: thebiotechinvestor.freeforums.net/attachment/download/135I was referring to the 10 min conf call after the quarterly earnings.
|
|
|
Post by JHam on Dec 19, 2014 13:47:36 GMT
Wasn't the last presentation Rodman & Renshaw? I remember him sayin there that they'd have data out in Q4, but that the new IND would be announced first half of 2015. I could be wrong though. Anyway, here is the slide showing the milestones from Rodman & Renshaw which was in Nov: thebiotechinvestor.freeforums.net/attachment/download/135I was referring to the 10 min conf call after the quarterly earnings. Then you may be correct. I have listened to so many presentations and calls over the past few weeks I can't remember which is which.
|
|
|
Post by JHam on Dec 19, 2014 15:19:09 GMT
Just added a little more at $3.39.
|
|
|
Post by JHam on Dec 19, 2014 21:05:36 GMT
And just added some more at the end. Not exactly how I was hoping to end the week with this one. Hopefully it was just people dumping who were thinking we'd get data news today.
|
|
|
Post by Yelk on Jan 10, 2015 21:19:46 GMT
So the next catalyst aside from upcoming conference is first half of 2016 for Ph II USA? Followed by/with multi-dose . I'm considering removing all my position of 0 catalysts for over a year. I currently have a very small one. I think this company has huge potential but it just may not be the best time to leave a good chunk in.
|
|
|
Post by JHam on Jan 10, 2015 22:37:25 GMT
So the next catalyst aside from upcoming conference is first half of 2016 for Ph II USA? Followed by/with multi-dose . I'm considering removing all my position of 0 catalysts for over a year. I currently have a very small one. I think this company has huge potential but it just may not be the best time to leave a good chunk in. Yes and no. They will announce the next indication sometime in the near future, if that is Parkinson's or MS it could cause a spike. The announcement of the multi-dose trial could also cause a jump, but who knows. In terms of final data results, yes it looks like 2016 for P2 USA. However, interim data will be before that, maybe even by the end of this year since they have been enrolling patients for a while now. Now that they have beefed up their cash position and gotten fundraising out of the way, I don't feel much risk in holding this stock for a while now. However like you mentioned, there may not be any big movement for a while. I am not dying to get back in at the moment and have most of my funds currently tied up in other stocks. If this continues to go lower I may start a small position again though, as I'd rather buy low and hold for a little bit, than buy higher later. I am not sure if we'll see the $3s again.
|
|
|
Post by Yelk on Jan 10, 2015 22:46:30 GMT
I definitely am not out for more then a few months but I am thinking this may go down below 4 easily before we see complete resistance and work away back to interim results. But I have such a small position I might just leave it and add when I see final resistance. Thanks for the note Jham.
|
|